Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-006127
Filing Date
2023-03-06
Accepted
2023-03-06 08:50:59
Documents
4
Period of Report
2023-05-03

Document Format Files

Seq Description Document Type Size
1 PRE 14A proxy_agm_2023.htm PRE 14A 1768812
2 GRAPHIC img150832104_0.jpg GRAPHIC 4586
3 GRAPHIC img150832104_1.jpg GRAPHIC 78671
4 GRAPHIC img150832104_2.jpg GRAPHIC 90815
  Complete submission text file 0000950170-23-006127.txt   2010082
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38503 | Film No.: 23707701
SIC: 2834 Pharmaceutical Preparations